标题/作者	年份
18F-labeled, PSMA-targeted radiotracers: leveraging the advantages of radiofluorination for prostate cancer molecular imaging RA Werner, T Derlin, C Lapa, S Sheikbahaei, T Higuchi, FL Giesel, S Behr, ... Theranostics 10 (1), 1	2020
A prospective comparison of 18F-prostate-specific membrane antigen-1007 positron emission tomography computed tomography, whole-body 1.5 T magnetic resonance imaging with diffusion-weighted imaging, and single-photon emission computed tomography/computed tomography with traditional imaging in primary distant metastasis staging of prostate cancer (PROSTAGE) M Anttinen, O Ettala, S Malaspina, I Jambor, M Sandell, S Kajander, ... European urology oncology 4 (4), 635-644	2021
68Ga-PSMA PET/CT for primary lymph node and distant metastasis NM staging of high-risk prostate cancer S Klingenberg, MR Jochumsen, BP Ulhøi, J Fredsøe, KD Sørensen, ... Journal of Nuclear Medicine 62 (2), 214-220	2021
Matched-pair comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in patients with primary and biochemical recurrence of prostate cancer: Frequency of non–tumor-related uptake and tumor positivity M Kroenke, L Mirzoyan, T Horn, JC Peeken, A Wurzer, HJ Wester, ... Journal of Nuclear Medicine 62 (8), 1082-1088	2021
Prostate-specific membrane antigen PET in prostate cancer C Lawhn-Heath, A Salavati, SC Behr, SP Rowe, J Calais, WP Fendler, ... Radiology 299 (2), 248-260	2021
Assessment of biochemical recurrence of prostate cancer X Lin, A Kapoor, Y Gu, MJ Chow, H Xu, P Major, D Tang International journal of oncology 55 (6), 1194-1212	2019
Molecular imaging: a novel tool to visualize pathogenesis of infections in situ O Gordon, CA Ruiz-Bedoya, AA Ordonez, EW Tucker, SK Jain MBio 10 (5), 10.1128/mbio. 00317-19	2019
Intraindividual comparison of [68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysis S Hoberück, S Löck, A Borkowetz, U Sommer, R Winzer, K Zöphel, ... EJNMMI research 11 (1), 1-18	2021
Recent updates on molecular imaging reporting and data Systems (MI-RADS) for theranostic radiotracers—navigating pitfalls of SSTR-and PSMA-targeted PET/CT RA Werner, JT Thackeray, MG Pomper, FM Bengel, MA Gorin, T Derlin, ... Journal of Clinical Medicine 8 (7), 1060	2019
Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting AK Miyahira, KJ Pienta, JW Babich, NH Bander, J Calais, P Choyke, ... The Prostate 80 (15), 1273-1296	2020
Salvage therapy for prostate cancer after radical prostatectomy NG Zaorsky, J Calais, S Fanti, D Tilki, T Dorff, DE Spratt, AU Kishan Nature Reviews Urology 18 (11), 643-668	2021
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen–Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide KA Zukotynski, U Emmenegger, S Hotte, A Kapoor, W Fu, AL Blackford, ... Journal of Nuclear Medicine 62 (10), 1430-1437	2021
Pharmacokinetic studies of [68 Ga] Ga-PSMA-11 in patients with biochemical recurrence of prostate cancer: detection, differences in temporal distribution and kinetic modelling by tissue type DS Strauss, C Sachpekidis, K Kopka, L Pan, U Haberkorn, ... European journal of nuclear medicine and molecular imaging 48 (13), 4472-4482	2021
More than meets the eye: scientific rationale behind molecular imaging and therapeutic targeting of prostate-specific membrane antigen (PSMA) in metastatic prostate cancer and beyond A Hyväkkä, V Virtanen, J Kemppainen, TJ Grönroos, H Minn, M Sundvall Cancers 13 (9), 2244	2021
PET imaging for prostate cancer B Savir-Baruch, RA Werner, SP Rowe, DM Schuster Radiologic Clinics 59 (5), 801-811	2021
Ultrasonic-Assisted Solid-Phase Peptide Synthesis of DOTA-TATE and DOTA-linker-TATE Derivatives as a Simple and Low-Cost Method for the Facile Synthesis of Chelator–Peptide Conjugates SJ Raheem, BW Schmidt, VR Solomon, AK Salih, EW Price Bioconjugate Chemistry 32 (7), 1204-1213	2020
[18F] DCFPyL PET/CT for imaging of prostate cancer SP Rowe, A Buck, RA Bundschuh, C Lapa, SE Serfling, T Derlin, ... Nuklearmedizin-NuclearMedicine	2022
18F-DCFPyL PET acquisition, interpretation, and reporting: suggestions after Food and drug administration approval H Song, A Iagaru, SP Rowe Journal of Nuclear Medicine 63 (6), 855-859	2022
Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy E Mena, SP Rowe, JH Shih, L Lindenberg, B Turkbey, A Fourquet, FI Lin, ... Journal of Nuclear Medicine 63 (8), 1184-1190	2022
FAPI-04 Uptake in Healthy Tissues of Cancer Patients in 68 Ga-FAPI-04 PET/CT Imaging C Gündoğan, Y Güzel, C Can, İ Kaplan, H Kömek Contrast media & molecular imaging 2021	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。